1. Introduction {#s0005}
===============

Amyotrophic lateral sclerosis is a progressive neurodegenerative condition characterized by upper and lower motor neuron degeneration ([@bb0185]). Extra-motor behavioural and cognitive symptoms are common in ALS ([@bb0335]), and imaging technologies have provided early evidence of broader network disruption ([@bb0025], [@bb0030]).

Although structural imaging can reliably record changes in grey and white matter integrity ([@bb0390]) and functional imaging detects resting and activated states of metabolic activity ([@bb0110]), there remains an unmet need for real-time measurement of different patterns of network disruption.

1.1. EEG for assessing neural function {#s0010}
--------------------------------------

Electrophysiological measurement of network activity during cognitive performance allows for direct objective quantification of dysfunction ([@bb0180]) with excellent temporal resolution ([@bb0410]). These measures, captured by EEG or MEG, are distinct from secondary blood flow or oxygen content measures upon which fMRI is based ([@bb0110]). EEG measures the electrical dipoles produced by transmembrane ion flow in large numbers of simultaneously-active, aligned cortical neurons, while MEG measures the concurrently generated magnetic fields ([@bb0070]). EEG/MEG measurements have traditionally been limited by noise from extracerebral (such as facial muscles, ocular, and cardiac) artefacts, in addition to poor spatial resolution ([@bb0355]). However, the use of improved recording instrumentation with up to 256 sensors, combined with digitized data processing ([@bb0095]; [@bb0250]; [@bb0295]), has substantially improved the signal to noise ratio.

Due to volume conduction, EEG sensors capture electrical currents propagated from both adjacent and distant sources in the conductive human head medium. However, source localisation of EEG sensor recordings localises the activity underlying these signals with spatial resolution comparable to fMRI ([@bb0235]) and source localised MEG ([@bb0245]). Furthermore, as EEG does not require expensive superconductive systems needed for MEG ([@bb0445]), it is more cost effective and therefore more suited to day-to-day clinical application.

As EEG/MEG directly measure the functional neuronal activity at a network level, they can capture cognitive network dysfunction in the absence of cognitive symptoms ([@bb0085]), and therefore may provide greater sensitivity to cognitive pathology than psychological (behavioural) task parameters. Correlating these measures with specific domains of cognitive impairment could provide quantifiable cognitive biomarkers to improve neurodegenerative disease diagnostics, and additional outcome measures for clinical trials.

1.2. MMN an index of cognitive decline {#s0015}
--------------------------------------

MMN is a measure typically elicited and recorded during an auditory oddball task, wherein the participant receives series of auditory stimuli (tones). These tones are of one pitch, except for a fraction of cases (e.g. 10% in this study) which are of higher "deviant" frequency (pitch). The MMN is a negative waveform, found by the difference between the auditory evoked potentials generated by these deviant and standard tones at 100-300 ms post-stimulus ([@bb0165]; [@bb0275]; [@bb0255]).

Multiple hypotheses have been proposed regarding the cortical function(s) measured by MMN, including both sensory and cognitive components of auditory processing. MMN was first described by Näätänen et al. in 1978, who hypothesised that the waveform resulted from comparison of a deviant input to a sensory memory template. It was also suggested that MMN might represent recognition of target criteria fulfilment ([@bb0270]), however such a "relevance effect" was considered unlikely as attention to the stimulus did not affect the waveform ([@bb0260]). This was subsequently supported by multiple studies demonstrating MMN in the absence of attention ([@bb0455]), including in sleeping infants ([@bb0365]) or those in a vegetative state ([@bb0450]). The MMN was therefore proposed to reflect an automatic detection of sensory change and modification of the physiological model of the environment to incorporate this new stimulus, referred to as the *model adjustment hypothesis* ([@bb0455]).

An additional automatic attention-switching process related to the frontal generators was then proposed to occur on the basis that right frontal sources were activated irrespective of the ear detecting the stimulus change ([@bb0135]). This is believed to reflect the call to switch attention to changes in the unattended environment ([@bb0455]), the occurrence of which is supported by autonomic responses such as heart rate and skin conductance changes following MMN ([@bb0195]) as well as many other studies ([@bb0115], [@bb0120]; [@bb0385]).

An alternative *adaptation hypothesis,* first proposed by May et al. in 1999 ([@bb0225]; [@bb0210], [@bb0215]), proposes that the MMN response results from cortical adaptation to monotonous stimuli, with MMN reflecting the difference between N1 to a novel sound and a lower amplitude, higher latency N1 generated by repetitive standard tones. This hypothesis was supported by later studies, such as those of Jääskeläinen et al. ([@bb0170]) and Ulanovsky et al., ([@bb0425]) (for review see ([@bb0220])). However, an exclusively auditory hypotheses cannot account for the established prefrontal activation during MMN. Indeed, source localisation of PET, EEG, fMRI and MEG-derived MMN has reliably highlighted both the superior temporal and inferior frontal gyri as important sources of this signal ([@bb0360]; [@bb0325]; [@bb0460]; [@bb0240]), demonstrating that volume conduction alone does not account for frontal MMN. Furthermore, those with lesions of the dorsolateral prefrontal cortex have also been found to have reduced MMN amplitudes ([@bb0015]).

Source localisation across the MMN timeframe has additionally revealed two subcomponents, an early, sensory component that is maximal in the late N1 range (105-125 ms post-stimulus) generated by temporal sources and a later, cognitive component (170-200 ms post-stimulus), generated by frontal and temporal sources ([@bb0135]; [@bb0360]; [@bb0205]). These temporal sources are attributed to sensory memory and change detection while the later active, frontal sources are attributed to involuntary attention switching in response to change ([@bb0135]; [@bb0360]; [@bb0010]; [@bb0265]). As this early component overlaps with the N1 range, temporal activity may also represent sensory detection ([@bb0220]).

Hence, source-localised MMN affords the benefit of separately interrogating each of these functions and the neural network which generate them, both in healthy individuals and those with neurological diseases. This is supported by several previous studies in different neurological and neuropsychiatric diseases, where MMN has been used as an index of abnormal auditory perception, involuntary attention switching, pathological brain excitability and cognitive and functional decline (see ([@bb0280], [@bb0285]; [@bb0370]; [@bb0415]; [@bb0190]) for reviews).

1.3. Identifying the sources of MMN change in ALS {#s0020}
-------------------------------------------------

Using qEEG to measure MMN, we recently have shown a functional change in the underlying networks in ALS, with MMN being significant in healthy controls from 105 to 271 ms post-stimulus and having an increased average delay within the 100-300 ms post-stimulus window in ALS ([@bb0165]). Due to the limited spatial resolution of sensor space studies, however, the specific sources contributing to MMN change and the nature of their dysfunction in ALS remains unclear. We therefore were unable to specify which network components indexed by MMN are affected by ALS pathology.

In this study we have used high-density qEEG in combination with each of three source localisation methods to determine and cross-validate the locations of MMN generators, and to measure differences in their activity between ALS patients and healthy controls. Here we show how the dysfunction of each source of MMN is affected by ALS, characterized by both under-active and over-active sources contributing to the abnormal response.

2. Methods {#s0025}
==========

2.1. Ethical approval {#s0030}
---------------------

Ethical approval was obtained from the ethics committee of Beaumont Hospital (REC reference: ([@bb0295])/102) and the St. James\'s Hospital (REC reference: 2017--02). All participants provided written informed consent before participation. All work was performed in accordance with the Declaration of Helsinki.

2.2. Participants {#s0035}
-----------------

### 2.2.1. Recruitment {#s0040}

Patient recruitment was undertaken from the National ALS specialty clinic in Beaumont Hospital. Healthy controls included neurologically-normal spouses of ALS patients and neurologically-normal, age- and sex-matched individuals recruited from an existing cohort of population-based controls.

### 2.2.2. Inclusion criteria {#s0045}

Patients were over 18 years of age and diagnosed within the previous 18 months with Possible, Probable or Definite ALS in accordance with the El Escorial Revised Diagnostic Criteria.

### 2.2.3. Exclusion criteria {#s0050}

Patients with Transient Ischemic Attack, Multiple Sclerosis, stroke, seizure disorders, brain tumours, structural brain diseases and other comorbidities were excluded.

### 2.2.4. Demographics of patients and controls {#s0055}

A total of 95 ALS patients and 43 controls underwent recording. 58 ALS patients (f/m: 20/38; age: 59.2 years, range: 29--81 years) and 39 healthy controls (f/m: 28/11; age: 58.9 years, range: 36--78 years) were included in final analyses. Data with poor recording quality (determined by the lack of auditory evoked potentials), were excluded. Eight controls and 44 patients were also included in our previous sensor-space analysis ([@bb0165]).

### 2.2.5. Medical profile {#s0060}

Within the ALS group, 44 patients had spinal onset, 12 bulbar, and 2 thoracic onset. All patients were tested for the hexanucleotide repeat expansion in *C9ORF72*, of whom 7 were positive (*C9ORF72*+). Twelve patients had a known family history of at least one first or second degree relative with ALS, 3 of whom carried the *C9ORF72* repeat expansion. One additional patient had a known family history of at least one first or second degree relative with frontotemporal dementia ([@bb0050]). A contemporaneous ALSFRS-R score was available in 51 patients. Mean ALSFRS-R was 37.8 with an IQR of 33.5--42. Mean disease duration was 1.83 years (IQR: 0.89--2.09) from estimated symptom onset.

2.3. Experimental paradigm {#s0065}
--------------------------

EEG was recorded across 128-channels in 3 consecutive, 8 min sessions, during which an auditory frequency-mismatch oddball paradigm was delivered as described in our previously reported methods ([@bb0165]). In total, 1350 standard trials and 150 deviant trials were presented.

2.4. Data acquisition {#s0070}
---------------------

EEG recordings were conducted in the Clinical Research Facility at St. James\'s Hospital, Dublin using a BioSemi® ActiveTwo system (BioSemi B.V., Amsterdam, The Netherlands) within a Faraday cage. Subjects were measured with an appropriately-sized EEG cap. Data were online filtered to a bandwidth of 0--134 Hz and digitized at 512 Hz. Common average referencing was used. 27 patients also undertook the Colour-Word Interference Test from the Delis-Kaplan Executive Function System ([@bb0080]), which is a test of attention shift, inhibitory control, error monitoring and cognitive flexibility.

2.5. Data analysis {#s0075}
------------------

Data were preprocessed as described in our previous sensor space analysis ([@bb0165]) using custom MATLAB (version R2014a and R2016a, Mathworks Inc., Natick, MA, USA) scripts and the FieldTrip Toolbox ([@bb0320]). Mean number of included artefact-free standard/deviant trials was 1267/144 for patients and 1223/146 for controls. For source analyses the number of standard trials was matched to that of deviant trials by random selection.

2.6. EEG signal processing {#s0080}
--------------------------

The mean standard and deviant auditory evoked potentials were calculated for each participant from 100 ms before the stimulus to 500 ms post-stimulus as previously reported ([@bb0165]). MMN waveforms were calculated for each electrode in each individual as the difference between mean deviant and standard AEPs. Channels with continuously noisy data were excluded (mean excluded channels ± standard deviation in controls: 1.59 ± 1.65, patients: 1.52 ± 1.55) and data from these channels were modelled by spline interpolation of neighbouring channels.

2.7. Source localisation and analysis {#s0085}
-------------------------------------

Source localisation was implemented using custom MATLAB (version R2016a) scripts and the FieldTrip Toolbox for linearly constrained minimum variance ([@bb0430]) beamforming and dipole fitting, as well as LORETA-KEY software (version 20170220, The KEY Institute for Brain-Mind Research, Zurich, Switzerland) for exact low-resolution electrotomography ([@bb0330]). Three different source localisation methods were used to circumvent the limitations imposed by different mathematical assumptions for finding a unique solution to the 'inverse problem' by each single method ([@bb0075]) ([Table 1](#t0005){ref-type="table"}). Head models incorporating individual geometries for the brain, skull and scalp tissues were constructed for 41 patients. Boundary-element head models ([@bb0130]) were generated using T1 images from contemporaneous MRI (3-Tesla Philips Achieva scanner, Best, The Netherlands), acquired at the Centre of Advanced Medical Imaging, St. James\' Hospital ([@bb0390]). For other subjects with no personal MRI, the ICBM152 head model ([@bb0125]) was used, as template-based and individualised boundary-element head models are found to provide comparable localisation accuracy ([@bb0130]; [@bb0090]).Table 1Limitations and advantages of different source localisation methods.Table 1MethodDipole fittingLCMVeLORETASpatial resolutionExcellentGoodLowTemporally correlated source detectionNo limitationLimitedNo limitationPrior knowledge requiredYesNoNoFull brain map estimateNoYesGrey-matter

### 2.7.1. Linearly constrained minimum variance (LCMV) {#s0090}

LCMV is a beamforming source localisation method wherein the covariance of the signals recorded from the electrodes is used to generate a spatial filter formed by a linear combination of electrode weights, for each grid point in the brain. The identified solution is that which affords minimum experimental variance of data when projected to the source, thus minimising the amount of activity from other sources ([@bb0430]). LCMV was used to calculate brain maps of mean power for the average AEP 100-300 ms after standard and deviant cues, based on a common spatial filter. A time window of 100-300 ms was utilised to ensure accurate calculation of the covariance matrix from which the spatial filter is calculated and avoid high functional correlation between the sources which would hinder localisation of such distinct sources. Covariance matrices were also calculated for individual trials to minimise such correlations. Regularisation of the covariance matrix was implemented at 5% of the average variance of EEG electrodes to account for reduced dimensionality caused by independent component analysis during preprocessing. Sources within the brain volume were modelled by a grid with 10 mm resolution. The leadfield matrix was normalised to avoid potential norm artefacts. Sources of MMN activity were identified by the locations of the maximal logarithm of the power ratio between deviant and standard maps.

### 2.7.2. Exact low resolution brain electromagnetic tomography (eLORETA) {#s0095}

ELORETA ([@bb0330]) identifies a unique source power map based on the implicit assumption that neighbouring dipoles have similar activity (low spatial resolution). This is achieved by identifying the solution with the least activity norm, subject to minimising the Laplacian (spatial gradient or derivative) of the sources. This assumption yields solutions with a relatively low spatial resolution. ELORETA was also used to calculate mean source power maps of the average auditory evoked potential 100-300 ms after standard and deviant cues to match the data input to LCMV. LORETA-KEY software models sources at 5 mm resolution within the brain volume of a boundary-element headmodel based on the Colin27 average brain ([@bb0150]), excluding sources located within white matter. For statistical comparison, grid resolution was reduced to 10 mm to avoid the loss of discriminatory power that may result from correction of over 6000 comparisons. Regularisation was implemented for a signal to noise ratio of 10. Sources of MMN activity were identified as described for LCMV.

### 2.7.3. Dipole fitting {#s0100}

Dipole fitting can be used to generate least-square error models of the contributions of electrical dipoles to an EEG topographic distribution, given a-priori estimation of the number and location of contributing dipoles ([@bb0375]). Residual variance (the variance in the data not explained by the model) is used as a goodness-of-fit measure. Previous studies ([@bb0175]; [@bb0315]; [@bb0310]) have repeatedly identified MMN sources in the inferior frontal gyri and superior temporal gyri. As non-linear optimisation of the dipole location repetitively produced fits at local rather than global residual variance minima, four fixed dipoles were modelled at the centroid coordinates of the bilateral superior temporal gyri and pars triangularis of the inferior frontal gyri, as determined from an AAL atlas ([@bb0420]). Models were estimated based on the average MMN response (mean{deviant response}-mean{standard response}) for 40 ms surrounding the global field power peak between 105 and 271 ms post-stimulus, the period for which we previously found MMN to be significant ([@bb0165]). Subsequently, mean power for each dipole was calculated. The rationale for using this shorter time frame was based upon findings that these four sources better accounted for the data in this window (i.e. had smaller residual variance) than the longer time window of data 100-300 ms post-stimulus, as used for LCMV and eLORETA. A model generated using the longer 200 ms time window provided the same results as the model reported here.

2.8. Statistics {#s0105}
---------------

### 2.8.1. LCMV and eLORETA {#s0110}

A 10 mm grid in the brain volume yields 733 sources excluding white matter (as modelled by eLORETA) and 1726 sources including white matter (as modelled by LCMV). To analyse these high-dimensional data, 10% False Discovery Rate ([@bb0035]) was used as a frequentist methods for preliminary screening. Subsequently, Empirical Bayesian Inference (EBI) ([@bb0100]) was used to find Bayesian posterior probabilities, as well as achieved statistical power and AUROC. AUROC is a measure of how well the test separates patient and control groups ([@bb0145]) which ranges from 0 to 1, where if the null hypothesis of no separation is true, AUROC equals 0.5. Therefore, the further the value of AUROC from 0.5, the greater the separation.

### 2.8.2. Dipole fitting {#s0115}

Dipole power for each of the four modelled dipoles in the complete ALS group as well as *C9ORF72*+, *C9ORF72*−, bulbar-onset and spinal-onset subgroups were compared by Mann-Whitney *U* test. Bonferroni correction for multiple comparisons established a significance threshold of *p* \< .0025. AUROC and statistics were also calculated for each dipole by empirical bootstrapping-based inference ([@bb0290]).

### 2.8.3. Neuropsychology correlation {#s0120}

Spearman\'s rank partial correlation (which is inherently robust to outliers) was used to individually compare changes in EEG source power to CWIT performance (colour naming, word reading, inhibition and inhibition switching times in seconds) while correcting for speech impairment (ALS-FRS speech score on the day of testing) and age. CWIT was investigated on the basis of a previously identified correlation between sensor-level MMN average delay and performance in this task ([@bb0165]). Correlations were performed for power in each fitted dipoles and for the mean power in the left superior and medial frontal gyri (combined), primary motor cortex and posterior parietal cortex, according to the AAL atlas ([@bb0420]). Multiple comparison correction was by Bonferroni correction. Beaumont Behavioural Inventory ([@bb0105]) and Edinburgh Cognitive Assessment Score ([@bb0340]) data were also available, however the main scores of these measures showed no significant correlation to source activity and were, therefore, not investigated further.

3. Results {#s0125}
==========

3.1. Dipole fitting {#s0130}
-------------------

Locations of dipole fits are illustrated in [Fig. 1](#f0005){ref-type="fig"}. Control and patient groups showed similar goodness of fit (median (IQR): patients: 23.32% (15.24--30.2%), controls: 24.39% (15.55--35.49%)). *P*-values obtained by Mann-Whitney *U* test comparison of dipole power between ALS patients and healthy controls are summarised in [Table 2](#t0010){ref-type="table"}. Power was significantly lower in the IFG bilaterally as well as the left STG. AUROC demonstrated that power in each of these three dipoles has good group discrimination ability ([Table 2](#t0010){ref-type="table"}, [Fig. 2](#f0010){ref-type="fig"}). No differences were found between male and female patients for any dipole (*p* = .27--.75, AUROC = 0.42--0.58). The discrepancy from complete fit indicated the presence of additional sources, which were subsequently aggregated by eLORETA and LCMV.Fig. 1Location of dipoles modelled by dipole fitting. Centroids of the left (blue) and right (orange) superior temporal gyri and left (red) and right (green) inferior frontal pars triangularis were used to seed dipoles for dipole fitting. Axial MRI view is from above (L-Left, R-Right).Fig. 1Table 2Summary of P-values and AUROCs for each source modelled by dipole fitting in ALS patients and subgroups compared to controls. All subgroups show decreased power in inferior frontal and left temporal dipoles compared to controls. Inferior frontal activity has excellent discrimination ability between *C9ORF72*+ patients and controls and good discriminating ability in other groups. P-values were obtained by Mann-Whitney U test. AUROC given in parentheses. Bold indicates statistical significance (*p* \< .0025).Table 2Dipole LocationAllC9orf72+C9orf72-Bulbar-onsetSpinal-onsetLeft IFG**5.16 × 10**^**−6**^**6.87 × 10**^**−4**^**1.98 × 10**^**−5**^**1.22 × 10**^**−3**^**1.22 × 10**^**−3**^(0.7741)(0.9084)(0.7637)(0.802)(0.769)Right IFG**1.07 × 10**^**−5**^**2.15 × 10**^**−4**^**9.29 × 10**^**−5**^**2.37 × 10**^**−5**^**1.74 × 10**^**−4**^(0.7648)(0.9451)(0.7416)(0.895)(0.74)Left STG**9.30 × 10**^**−6**^0.016**2.30 × 10**^**−6**^2.64 × 10^−3^**2.40 × 10**^**−4**^(0.7666)(0.7912)(0.761)(0.795)(0.738)Right STG0.0810.390.1180.0350.23(0.6052)(0.6044)(0.5968)(0.698)(0.576)Fig. 2ALS patients show decreased power in both inferior frontal gyri and the left superior temporal gyrus. Boxes illustrate the interquartile range with whiskers illustrating the maximum and minimum power (A-m) within twice the interquartile range for ALS patients (P) and controls (C), determined by dipole fitting. Outliers are illustrated in black. Dashed line caps up to two outliers beyond this value. L -- Left, R -- Right, IFG -- Inferior frontal gyrus, STG -- Superior Temporal Gyrus.Fig. 2

3.2. eLORETA {#s0135}
------------

ELORETA identified maximal intensity of neural activity during MMN in the left IFG and bilateral STG and MTG in controls ([Fig. 3](#f0015){ref-type="fig"}a), confirming the localisation of major sources to those previously established, with the exception of the right IFG ([@bb0175]; [@bb0315]; [@bb0310]). ALS patients showed a pattern of reduced activity in these sources, consistent with the results of dipole fitting, as well as an increase in activity in posterior sources ([Fig. 3](#f0015){ref-type="fig"}b). While the eLORETA estimated the general distribution pattern of activity, the method\'s low spatial resolution prevented the effects reaching statistical significance.Fig. 3ELORETA identified a pattern of decreased activity in the left superior temporal and inferior frontal sources, and an increase in activity in posterior areas. Location of MMN sources with (a) top 50% of power (10\*log~10~(Deviant power / Standard power)) in healthy controls and (b) power differences \>25% of maximum between ALS patients and healthy controls as determined by eLORETA. Red denotes increase in power, blue denotes decrease in power. Axial MRI views are from above (L-Left, R-Right).Fig. 3

3.3. LCMV {#s0140}
---------

LCMV identified sources of MMN similar to the findings of eLORETA ([Fig. 4](#f0020){ref-type="fig"}a) but also identifying the right IFG as a source, as identified by previous studies ([@bb0175]; [@bb0315]; [@bb0310]). LCMV also detected a trend of reduced activity in these sources bilaterally, in keeping with the results of dipole fitting and eLORETA, as well as an increase in activity in the left parietal, central and dorsolateral prefrontal cortex ([Fig. 4](#f0020){ref-type="fig"}b). This increase reached statistical significance ([Fig. 5](#f0025){ref-type="fig"}, FDR = 10%, statistical power = 0.58). Based on interpolation with an AAL atlas, sources with significantly increased activity included the superior parietal lobe and precuneus, left motor structures including the primary motor cortex, supplementary motor area and mid cingulum, as well as the mid frontal gyrus ([Table 3](#t0015){ref-type="table"}). Positive correlations ([Fig. 6](#f0030){ref-type="fig"}) were found between CWIT inhibition-switching time (but not other CWIT scores) and mean power in the left primary motor cortex (ρ = 0.45, *p* = .055), the superior and middle frontal gyri combined (ρ = 0.47, *p* = .031) and the posterior parietal cortex (ρ = 0.45, *p* = .042), where greater inhibition-switching score indicates more impaired cognitive flexibility and verbal inhibition ([@bb0405]). *P*-values below 0.05 in the prefrontal and parietal cortices did not survive multiple comparison correction, likely due to the low number of CWIT scores available. No significant differences were found between male and female patient sources (α~global~ = 0.92, β ~global~ = 0.075) or mean power of the left posterior parietal, motor or inferior frontal cortices (*p* = .56--.89).Fig. 4LCMV identified a pattern of decreased activity in bilateral superior temporal and inferior frontal sources, and an increase in activity in the left hemisphere. Location of MMN sources with (a) top 25% of power (10\*log~10~(Deviant power / Standard power)) in healthy controls and (b) power differences \>25% of maximum between ALS patients and healthy controls as determined by LCMV beamforming. Red denotes increase in power, blue denotes decrease in power. Axial MRI views are from above (L-Left, R-Right).Fig. 4Fig. 5Increased activity in the left posterior parietal, central and dorsolateral prefrontal cortex in ALS is statistically significant. Statistically significant (false discovery rate = 10%) differences in power between ALS patients and healthy controls as determined by LCMV. Heat map values are AUROC-0.5. Red denotes AUROC\>0.5, blue denotes decrease in AUROC\<0.5. Axial MRI views are from above (L-Left, R-Right).Fig. 5Table 3Comparison of the head and source models, time windows and detected source activity changes for each source localisation method used. L -- left, R -- right, IFG -- inferior frontal gyrus, STG -- superior temporal gyrus. Arrows represent direction of change in power. \*Statistically significant (*p* \< .0025). BEM -- Boundary element model.Table 3MethodHead/source modelTime (ms)L IFGR IFGL STGR STGOther significant source changesLCMVICBM152/personal MRI BEM, 10 mm grid100--300↓↓↓↓↑\* Left superior parietal lobe, precuneus, primary motor cortex, supplementary motor area, mid cingulum, mid frontal gyruseLORETAColin27 MRI BEM, 10 mm grid excl. white matter100--300↓↑↓↓NoneDipole fittingICBM152/personal MRI BEM, 4 dipoles105--271 & 100--300**↓\*↓\*↓\***↓N/AFig. 6Increased activity in the posterior parietal and dorsolateral prefrontal cortex correlates to poorer performance in cognitive switching tasks. Correlation of inhibition/switching score (in seconds) for 27 patients with mean power in the left primary motor cortex (red), posterior parietal cortex (PPC, green), and middle and superior frontal gyri (M/SFG, blue) illustrated by scatterplot with line of best fit.Fig. 6

3.4. Differences between ALS subgroups {#s0145}
--------------------------------------

*C9ORF72*+ patients were not distinguished from *C9ORF72*− patients by any localisation method, nor were bulbar-onset from spinal-onset patients. This was likely due to insufficient sample size. *C9ORF72*− and spinal subgroups individually showed similar patterns of significant difference to the full patient group across each localisation method. Bulbar and *C9ORF72*+ subgroups significantly differed from controls with respect to bilateral IFG dipole activity, and exhibited better discrimination ability (summarised in [Table 2](#t0010){ref-type="table"}). The discrimination ability of this difference was excellent for *C9ORF72*+ patients (AUROC\>0.9) with low AUROC variation (0.002 bilaterally). CWIT and speech score data were insufficient (*C9ORF72*+ *n* = 0, bulbar-onset *n* = 3) for correlation analyses.

4. Discussion {#s0150}
=============

This study demonstrates that source localization of cognitive event-related potentials measured by EEG reliably distinguishes attentional network changes in ALS patients compared to controls, particularly in subgroups with higher prevalence of cognitive impairment ([@bb0055]; [@bb0380]). Furthermore, this study indicates for the first time a correlation between the activities of specific sources underlying cognitive event-related potentials and cognitive performance in a neurodegenerative disease. Compared with controls, ALS patients show decreased activity in both inferior frontal gyri and the left superior temporal gyrus and increased left posterior parietal and dorsolateral prefrontal activity. ALS patients also show significantly increased activity in the left motor cortex.

4.1. Imbalance of attention-regulating network activity during sensory processing in ALS {#s0155}
----------------------------------------------------------------------------------------

The superior temporal and inferior frontal gyri are well established sources of MMN activity ([@bb0205]; [@bb0175]; [@bb0200]). In this study, decreased activity in these regions was identified independently using each of the methods, however, dipole fitting allowed for a more temporally and spatially precise interrogation of these sources.

Repetitive TMS ([@bb0305]) and nonword rhyming task studies ([@bb0045]) have demonstrated the role of the IFG in phonological working memory, where information about one stimulus is stored for later comparison to a second. The IFG is also known to be active when ignoring stimuli ([@bb0040]) and is functionally connected to the default mode network ([@bb0020]). This network is active when directed attention is not required and is deactivated by goal-directed activity, as defined by resting-state fMRI ([@bb0350]). The activity of the default mode network is anti-correlated with that of the central executive network, where attention needs to be directed to a task ([@bb0300]). Inferior frontal source activity during the MMN is therefore consistent with calling for a switch of attention to changes in the unattended environment (i.e. involuntary attention switching), to which prefrontal MMN sources have previously been attributed ([@bb0455]; [@bb0135]).

The observed substantial reduction in IFG activity in ALS is correspondingly expected to parallel impairments in these cognitive functions. As posterior parietal and dorsolateral prefrontal cortices are nodes of the central executive network ([@bb0395]), their abnormal activation in combination with IFG dysfunction during MMN in ALS may represent a loss of balance between the activity of these attention-regulating networks ([@bb0230]) resulting in dysregulation of involuntary attention switching.

As participants were asked to ignore and not respond to stimuli in this study, attention regulation could not be behaviourally measured during MMN recording. This hypothesis is, however, supported by our preliminary findings of a positive correlation between increases in left posterior parietal and dorsolateral prefrontal activity during MMN, and the inhibition/switching score of the CWIT (and not other subscores of the CWIT). This indicates that abnormal increase in the activity of this network conveys cognitive inflexibility and disinhibition ([@bb0405]). Such behavioural inflexibility and disinhibition is consistent with incorrect orientation to irrelevant stimuli and is expected in those with abnormal central executive network activation. Correspondingly, change in bilateral IFG activity was shown to be an excellent discriminator of *C9ORF72*+ and bulbar-onset ALS subgroups, which are more prone to cognitive impairment ([@bb0055]; [@bb0380]).

This imbalance hypothesis is also evidenced by data from previously reported functional connectivity studies in ALS. For example, resting-state MEG has identified increased functional connectivity between the left posterior cingulate and prefrontal cortices, as well as within and between posterior parietal cortices, in addition to increased overall parietal connectivity (e.g. node weight) ([@bb0345]). Furthermore, resting state fMRI has demonstrated increased left precuneus, posterior parietal and mid cingulate cortex connectivity in addition to decreased inferior frontal connectivity ([@bb0005]) in ALS. Accordingly, the frontoparietal hyperactivity and inferior frontal depression observed in our study may reflect a spread in pathological hyperactivity into cognitive networks, which in turn alters the balance in normal network activity. Activation of the central cortex in addition to cognitive network nodes during MMN in ALS may correspondingly represent abnormal activation of networks connecting motor and cognitive areas. This is consistent with previous physiological studies which have consistently identified hyperactivity in upper motor neurons in ALS ([@bb0435]) and loss of inhibitory control ([@bb0140]).

ALS-FRS-R total score showed no correlation to source activity - this is likely a reflection of the relatively low burden disease in the majority of patients, and the study being underpowered to explore the subscores of ALSFRS-R. However, previous studies have shown that functional connectivity is increased with ALS and correlates with disease severity ([@bb0400]). A reduction in MMN in healthy individuals is also found to parallel increased connectivity and decreased inhibitory control between underlying sources, particularly in frontal nodes ([@bb0060]). The recently demonstrated relationship between cognitive impairment and disease stage in ALS ([@bb0065]) is therefore likely to reflect the spread of hyperactivity from motor to cognitive networks.

4.2. Potentially abnormal function of auditory network in ALS {#s0160}
-------------------------------------------------------------

Temporal source activity has been attributed predominantly to sensory memory and change detection in early MMN ([@bb0135]; [@bb0360]; [@bb0010]; [@bb0265]); however, it has also been found to contribute to MMN\'s later attention switching component ([@bb0205]). Furthermore, as the difference wave early in the 100-300 ms studied may also capture changes in N1 ([@bb0220]), temporal activity may include sensory detection.

As STG contains the primary auditory cortex ([@bb0160]) and has been shown to be active during attention control ([@bb0155]), the decrease in left STG activity identified here in ALS may represent impairment in either auditory or cognitive networks. These findings, in addition to the greater number of (excluded) patients lacking clear AEPs compared to controls, suggest the additional presence of auditory network dysfunction in ALS. An additional investigation of AEPs generated during a solely auditory task is required to investigate this network further in ALS.

4.3. Harnessing the advantages of quantitative EEG {#s0165}
--------------------------------------------------

The detected changes in ALS reflect the additive benefits of physiological investigation to those of structural imaging. The discriminative ability of these changes, determined by the AUROC (up to 0.95 here) was comparable to, or better than, that achieved by fMRI (AUROC = 0.714) ([@bb0440]) and sensor space qEEG (AUROC = 0.69) ([@bb0165]). This methodology therefore has the potential to provide neurodegenerative disease markers prior to the onset of discernible structural degeneration, allowing for earlier and more sensitive monitoring of potential interventions.

4.4. Limitations {#s0170}
----------------

A sample size of 58 patients and limited availability of psychological and clinical test scores restricted exploration of the relationship between cognitive symptoms and source activity within subgroups of this heterogeneous condition. Further studies of larger sample size are therefore warranted to explore such relationships and ALS inter-subgroup differences with greater statistical power.

4.5. Conclusion {#s0175}
---------------

In conclusion, combining multiple localisation methods to determine the sources of ERPs provides high spatial resolution to complement qEEGs\' excellent temporal resolution in the investigation of ALS-related network dysfunction. The use of this approach to localise activity during other cognitive, motor and sensory tasks allows for detailed interrogation of the location and nature of brain network disruption in neurodegenerative disorder**s**, with the potential to provide early, non-invasive and inexpensive biomarkers of neurodegenerations or their subtypes.
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